Subcutaneous live flu injection protected mice at 277 days without detectable lung virus
A mouse study found 100% survival at 277 days after a single subcutaneous live influenza injection, with no detectable infectious ...
A mouse study found 100% survival at 277 days after a single subcutaneous live influenza injection, with no detectable infectious ...
A randomized trial in 300 infants found that a Sabin strain-based inactivated polio vaccine induced seroconversion rates of 91.58% to ...
A study found anti-AAV3B neutralizing antibodies in 33%–36% of healthy adults, with intermediate titers in 19% of positive individuals, while ...
Bronchoalveolar lavage analysis reveals three distinct inflammatory phenotypes in post-COVID-19 lung disease and persistent SARS-CoV-2 spike protein up to two ...
A serosurvey of 1,303 people in eastern China found that toddlers aged 16 to 36 months have the lowest neutralizing ...
Cryo-electron microscopy of porcine neutralizing antibodies bound to foot-and-mouth disease virus reveals how mutations on VP1 and VP3 drive antigenic ...
Hedgehog merbecoviruses use aminopeptidase N as a functional entry receptor through a structurally distinct APN-binding mode, revealing convergent evolution and ...
A polyclonal secretory IgA preparation purified from pooled donor breast milk neutralized multiple respiratory viruses in vitro and reduced illness ...
A 2023 severe hand, foot and mouth disease outbreak in Vietnam was caused by a single introduction of enterovirus A71 ...
New research shows that antibodies targeting the fiber and nozzle proteins of an Acinetobacter baumannii phage block infection and accelerate ...
A new cryo-EM and biophysical study shows that removing the N153 glycan from dengue virus 2 exposes previously hidden epitopes, ...
A large study of historically smallpox-vaccinated individuals finds residual but uneven immunity, with chronic disease and cancer linked to lower ...
A cross-sectional study of travelers entering Ghana through ten major land borders in 2022 found that over 92 percent carried ...
In a groundbreaking study, researchers have made significant strides in the development of a novel vaccine targeting the Coxsackie B1 ...
The ongoing global battle against COVID-19 has entered a new chapter with the introduction of the updated 2024-2025 vaccines, which ...
In a groundbreaking study conducted by Soppela et al., a novel vaccine utilizing virus-like particles (VLPs) derived from the Coxsackie ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.